➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Baxter
Express Scripts
Boehringer Ingelheim
Colorcon

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

BENTYL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Bentyl, and when can generic versions of Bentyl launch?

Bentyl is a drug marketed by Allergan and Aptalis Pharma Us and is included in three NDAs.

The generic ingredient in BENTYL is dicyclomine hydrochloride. There are four drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the dicyclomine hydrochloride profile page.

US Patents and Regulatory Information for BENTYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan BENTYL dicyclomine hydrochloride CAPSULE;ORAL 007409-003 Oct 15, 1984 DISCN Yes No   Start Trial   Start Trial   Start Trial
Allergan BENTYL dicyclomine hydrochloride TABLET;ORAL 007409-001 Oct 15, 1984 DISCN Yes No   Start Trial   Start Trial   Start Trial
Allergan BENTYL dicyclomine hydrochloride INJECTABLE;INJECTION 008370-001 Oct 15, 1984 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Aptalis Pharma Us BENTYL dicyclomine hydrochloride SYRUP;ORAL 007961-002 Oct 15, 1984 DISCN Yes No   Start Trial   Start Trial   Start Trial
Allergan BENTYL PRESERVATIVE FREE dicyclomine hydrochloride INJECTABLE;INJECTION 008370-002 Oct 15, 1984 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
McKesson
McKinsey
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.